Philips Healthcare (NYSE:PHG) subsidiary Respironics Inc. announced a new recall affecting a set of its V60 ventilators after the company received reports of 2 motor failures.
Respironics has already informed all of its U.S. customers and has updated 33 of the 116 affected units with new blowers, according to a press release.
The V60 devices are assist ventilators used to augment breathing in the hospital or at home for patients with respiratory failure, chronic respiratory insufficiency, or obstructive sleep apnea.
The affected devices were manufactured with a potential issue in the blower assembly which may result in a weak impeller, according to the company.
"This could subsequently cause the blower to cease functioning which would result in the failure of the V60 ventilator to deliver therapy to the patient due to the loss of ventilation," according to the report. "This could pose a risk for injury to the patient. The V60 ventilator will alert users to malfunctioning blowers by annunciating audible and visual alarms."
It’s the company’s 2nd ventilator recall this year, following January’s Class I recall of Trilogy 100 ventilators for manufacturing issues in its ventilators that the FDA said may result in patient injury or death.
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.